Biodesign is interested in emerging markets in Medical Devices and has established a number of connections in India, China and Singapore to explore those markets and the impact they have on the development of new technologies. Funding from the Freeman Spogli Institute and NIH has provided resources to study some of these areas with our partners.


  • Stanford-India Biodesign (SIB)
  • Rural Education Action Project (REAP)
  • All India Institute for Medical Sciences (AIIMS)
  • Indian Institute of Technology (IIT) Delhi
  • India School of Business (ISB)
  • Singapore-Stanford Biodesign (SSB) with support from A*STAR and EDB
  • National Institutes of Health (NIH) Grant 1RC4 TW008781-01
  • Vision in Practice


  • Barriers to Commercialization for Medical Technology in India
  • An Evaluation of “Vision in Practice” in China
  • Understanding the Current Status of Medical Technology in Rural China


We will post results of our research here.

Barriers to Commercialization

Case Studies

These small case studies were written by the Graduate School of Business' Program in Healthcare Innovation with input from Biodesign and its global projects.